Douglas B Johnson (Douglas Johnson)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 53

Top Topics

Ulcerative Colitis

Prognostic Factors

Basal Cell Carcinoma

Top Venues

Nature medicine

Nature communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Kylie Fletcher, Saba Rehman, Rebecca Irlmeier, Fei Ye, Douglas B Johnson
Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma. The oncologist (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Reilly G Fankhauser, Douglas B Johnson, Javid J Moslehi, Justin M Balko
Unveiling Cellular Identities and Gene Expression Pathways in Overlapping Myocarditis and Myositis. Cancer immunology research (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Levente Lippenszky, Kathleen F Mittendorf, Zoltán Kiss, Michele L LeNoue-Newton, Pablo Napan-Molina, Protiva Rahman, Cheng Ye, Balázs Laczi, Eszter Csernai, Neha M Jain, Marilyn E Holt, Christina N Maxwell, Madeleine Ball, Yufang Ma, Margaret B Mitchell, Douglas B Johnson, David S Smith, Ben Ho Park, Christine M Micheel, Daniel Fabbri, Jan Wolber, Travis J Osterman
Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data. JCO clinical cancer informatics 8 (2024)
Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, Marie Bretagne, John R Power, Javid J Moslehi, Paul Gougis, Damien Amelin, Agnès Dechartres, Lorenz H Lehmann, Pierre-Yves Courand, Jennifer Cautela, Joachim Alexandre, Adrien Procureur, Antoine Rozes, Sarah Leonard-Louis, Juan Qin, null null, Rémi Cheynier, Benedicte Charmeteau-De Muylder, Alban Redheuil, Florence Tubach, Jacques Cadranel, Audrey Milon, Stéphane Ederhy, Caroline Sévoz-Couche, Douglas B Johnson, Ian Pizzo, Toniemarie Catalan, Olivier Benveniste, Salim Salim Hayek, Yves Allenbach, Michelle Rosenzwajg, Charles Dolladille, Joe-Elie Salem
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nature medicine (2024)
Levente Lippenszky, Kathleen F Mittendorf, Zoltán Kiss, Michele L LeNoue-Newton, Pablo Napan-Molina, Protiva Rahman, Cheng Ye, Balázs Laczi, Eszter Csernai, Neha M Jain, Marilyn E Holt, Christina N Maxwell, Madeleine Ball, Yufang Ma, Margaret B Mitchell, Douglas B Johnson, David S Smith, Ben Ho Park, Christine M Micheel, Daniel Fabbri, Jan Wolber, Travis J Osterman
Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data. JCO clinical cancer informatics 8 (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Reilly G Fankhauser, Douglas B Johnson, Javid J Moslehi, Justin M Balko
Unveiling Cellular Identities and Gene Expression Pathways in Overlapping Myocarditis and Myositis. Cancer immunology research 12 (8) (2024)
Pooja Middha Kapoor, Rohit Thummalapalli, Michael J Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A Bejan, Eduardo Cardenas, Christina J Falcon, David M Faleck, null null, Matthew A Gubens, Scott Huntsman, Douglas B Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M Lovly, Megan H Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M Balko, Geoffrey Liu, Melinda C Aldrich, Adam J Schoenfeld, Elad Ziv
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. Nature communications 15 (1) (2024)
Levente Lippenszky, Kathleen F Mittendorf, Zoltán Kiss, Michele L LeNoue-Newton, Pablo Napan-Molina, Protiva Rahman, Cheng Ye, Balázs Laczi, Eszter Csernai, Neha M Jain, Marilyn E Holt, Christina N Maxwell, Madeleine Ball, Yufang Ma, Margaret B Mitchell, Douglas B Johnson, David S Smith, Ben Ho Park, Christine M Micheel, Daniel Fabbri, Jan Wolber, Travis J Osterman
Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data. JCO clinical cancer informatics 8 (2024)
Rachel S Goodman, Douglas B Johnson, Justin M Balko
Corticosteroids and Cancer Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, Marie Bretagne, John R Power, Javid J Moslehi, Paul Gougis, Damien Amelin, Agnès Dechartres, Lorenz H Lehmann, Pierre-Yves Courand, Jennifer Cautela, Joachim Alexandre, Adrien Procureur, Antoine Rozes, Sarah Leonard-Louis, Juan Qin, null null, Rémi Cheynier, Benedicte Charmeteau-De Muylder, Alban Redheuil, Florence Tubach, Jacques Cadranel, Audrey Milon, Stéphane Ederhy, Caroline Sévoz-Couche, Douglas B Johnson, Ian Pizzo, Toniemarie Catalan, Olivier Benveniste, Salim Salim Hayek, Yves Allenbach, Michelle Rosenzwajg, Charles Dolladille, Joe-Elie Salem
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nature medicine (2023)
Douglas B Johnson, Rachel S Goodman, J Patrinely, Cosby Stone, Eli Zimmerman, Rebecca Rigel Donald, Sam Chang, Sean Berkowitz, Avni Finn, Eiman Jahangir, Elizabeth Scoville, Tyler Reese, Debra Friedman, Julie Bastarache, Yuri van der Heijden, Jordan Wright, Nicholas Carter, Matthew Alexander, Jennifer Choe, Cody Chastain, John Zic, Sara Horst, Isik Turker, Rajiv Agarwal, Evan Osmundson, Kamran Idrees, Colleen Kiernan, Chandrasekhar Padmanabhan, Christina Bailey, Cameron Schlegel, Lola Chambless, Mike Gibson, Travis Osterman, Lee Wheless
Assessing the Accuracy and Reliability of AI-Generated Medical Responses: An Evaluation of the Chat-GPT Model. Research square (2023)
Sixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, Yan Wang, Xiao Zhang, Zhentao Yang, Raymond J Lim, Camelia Dumitras, Philip O Scumpia, Steven M Dubinett, Gatien Moriceau, Douglas B Johnson, Stergios J Moschos, Roger S Lo
Multi-organ landscape of therapy-resistant melanoma. Nature medicine 29 (5) (2023)
Rachel S Goodman, Douglas B Johnson, Justin M Balko
Corticosteroids and Cancer Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Amin H Nassar, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingjia Li, Arjun Mittra, Dwight H Owen, Robert A Baiocchi, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Adewunmi Falohun, Noha Abdel-Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G Lechner, Alexandra Drakaki, Javier Baena, Caroline A Nebhan, Tarek Haykal, Michael A Morse, Alessio Cortellini, David James Pinato, Alessia Dalla Pria, Evan Thomas Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal S Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui Lia, Danai Dima, Ryan W Dobbs, Pauline Funchain, Rabia Saleem, Rachel G Woodford, Georgina V Long, Alexander M Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin G Reid, Elizabeth Yu Chiao, Elad Sharon, Douglas B Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U Marron, Toni K Choueiri, Lindsey R Baden, Kathryn Lurain, Guru P Sonpavde, Abdul Rafeh Naqash
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, Yan Wang, Xiao Zhang, Zhentao Yang, Raymond J Lim, Camelia Dumitras, Philip O Scumpia, Steven M Dubinett, Gatien Moriceau, Douglas B Johnson, Stergios J Moschos, Roger S Lo
Multi-organ landscape of therapy-resistant melanoma. Nature medicine (2023)
Douglas B Johnson, Rachel S Goodman, J Patrinely, Cosby Stone, Eli Zimmerman, Rebecca Rigel Donald, Sam Chang, Sean Berkowitz, Avni Finn, Eiman Jahangir, Elizabeth Scoville, Tyler Reese, Debra Friedman, Julie Bastarache, Yuri van der Heijden, Jordan Wright, Nicholas Carter, Matthew Alexander, Jennifer Choe, Cody Chastain, John Zic, Sara Horst, Isik Turker, Rajiv Agarwal, Evan Osmundson, Kamran Idrees, Colleen Kiernan, Chandrasekhar Padmanabhan, Christina Bailey, Cameron Schlegel, Lola Chambless, Mike Gibson, Travis Osterman, Lee Wheless
Assessing the Accuracy and Reliability of AI-Generated Medical Responses: An Evaluation of the Chat-GPT Model. Research square (2023)
Ari M VanderWalde, Shay L Bellasea, Kari L Kendra, Nikhil I Khushalani, Katie M Campbell, Philip O Scumpia, Lawrence F Kuklinski, Frances Collichio, Jeffrey A Sosman, Alexandra P Ikeguchi, Adrienne I Victor, Thach-Giao Truong, Bartosz Chmielowski, David C Portnoy, Yuanbin Chen, Kim A Margolin, Charles Bane, Constantin A Dasanu, Douglas B Johnson, Zeynep Eroglu, Sunandana Chandra, Egmidio Medina, Cynthia R Gonzalez, Ignacio Baselga-Carretero, Agustin Vega-Crespo, Ivan Perez Garcilazo, Elad Sharon, Siwen Hu-Lieskovan, Sapna Pradyuman Patel, Kenneth F Grossmann, James Moon, Michael C Wu, Antoni Ribas
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial. Nature medicine (2023)
Douglas B Johnson, Alexander M Menzies
Combination immunomodulation for immune-checkpoint-inhibitor-associated myocarditis. Nature reviews. Clinical oncology (2023)
Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, Marie Bretagne, John R Power, Javid J Moslehi, Paul Gougis, Damien Amelin, Agnès Dechartres, Lorenz H Lehmann, Pierre-Yves Courand, Jennifer Cautela, Joachim Alexandre, Adrien Procureur, Antoine Rozes, Sarah Leonard-Louis, Juan Qin, null null, Rémi Cheynier, Benedicte Charmeteau-De Muylder, Alban Redheuil, Florence Tubach, Jacques Cadranel, Audrey Milon, Stéphane Ederhy, Caroline Sévoz-Couche, Douglas B Johnson, Ian Pizzo, Toniemarie Catalan, Olivier Benveniste, Salim Salim Hayek, Yves Allenbach, Michelle Rosenzwajg, Charles Dolladille, Joe-Elie Salem
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nature medicine (2023)
Amin H Nassar, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingjia Li, Arjun Mittra, Dwight H Owen, Robert A Baiocchi, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Adewunmi Falohun, Noha Abdel-Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G Lechner, Alexandra Drakaki, Javier Baena, Caroline A Nebhan, Tarek Haykal, Michael A Morse, Alessio Cortellini, David James Pinato, Alessia Dalla Pria, Evan Thomas Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal S Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui Lia, Danai Dima, Ryan W Dobbs, Pauline Funchain, Rabia Saleem, Rachel G Woodford, Georgina V Long, Alexander M Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin G Reid, Elizabeth Yu Chiao, Elad Sharon, Douglas B Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U Marron, Toni K Choueiri, Lindsey R Baden, Kathryn Lurain, Guru P Sonpavde, Abdul Rafeh Naqash
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Rachel S Goodman, Seungyeon Jung, Justin M Balko, Douglas B Johnson
Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities. Immunological reviews (2023)
Rachel S Goodman, Douglas B Johnson, Justin M Balko
Corticosteroids and Cancer Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Douglas B Johnson, Caroline A Nebhan, Javid J Moslehi, Justin M Balko
Immune-checkpoint inhibitors: long-term implications of toxicity. Nature reviews. Clinical oncology 19 (4) (2022)
Ines Pires daSilva, Tasnia Ahmed, Jennifer Leigh McQuade, Caroline A Nebhan, John J Park, Judith M Versluis, Patricio Serra-Bellver, Yasir Khan, Tim Slattery, Honey K Oberoi, Selma Ugurel, Lauren E Haydu, Rudolf Herbst, Jochen Utikal, Claudia Pföhler, Patrick Terheyden, Michael Weichenthal, Ralf Gutzmer, Peter Mohr, Rajat Rai, Jessica L Smith, Richard A Scolyer, Ana M Arance, Lisa Pickering, James M G Larkin, Paul C Lorigan, Christian U Blank, Dirk Schadendorf, Michael A Davies, Matteo S Carlino, Douglas B Johnson, Georgina V Long, Serigne N Lô, Alexander M Menzies
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2022)
Ying Jing, Jingwen Yang, Douglas B Johnson, Javid J Moslehi, Leng Han
Harnessing big data to characterize immune-related adverse events. Nature reviews. Clinical oncology 19 (4) (2022)
Margaret L Axelrod, Wouter C Meijers, Elles M Screever, Juan Qin, Mary Grace Carroll, Xiaopeng Sun, Elie Tannous, Yueli Zhang, Ayaka Sugiura, Brandie C Taylor, Ann Hanna, Shaoyi Zhang, Kaushik Amancherla, Warren Tai, Jordan J Wright, Spencer C Wei, Susan R Opalenik, Abigail L Toren, Jeffrey C Rathmell, Paul Brent Ferrell, Elizabeth Jane Phillips, Simon Mallal, Douglas B Johnson, James P Allison, Javid J Moslehi, Justin M Balko
T cells specific for α-myosin drive immunotherapy-related myocarditis. Nature 611 (7937) (2022)
Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra P Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason J Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Howard M Goodall, Koustubh Ranade, Chris Holland, Shaad E Abdullah, Joseph J Sacco, Takami Sato
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial. Nature medicine 28 (11) (2022)
Rachel Goodman, Douglas B Johnson
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies. Current treatment options in oncology 23 (10) (2022)
Jordan J Wright, Douglas B Johnson
APPROACH TO THE PATIENT WITH IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED ENDOCRINE DYSFUNCTION. The Journal of clinical endocrinology and metabolism (2022)
Seungyeon Jung, Emma Armstrong, Alexander Z Wei, Fei Ye, Aaron Lee, Matteo S Carlino, Ryan J Sullivan, Richard D Carvajal, Alexander N Shoushtari, Douglas B Johnson
Clinical and genomic correlates of imatinib response in melanomas with KIT alterations. British journal of cancer 127 (9) (2022)
Abdul Rafeh Naqash, Melissa Y Y Moey, Xiao-Wei Cherie Tan, Mehak Laharwal, Vanessa Hill, Nagabhishek Moka, Shanda R Finnigan, James Murray, Douglas B Johnson, Javid J Moslehi, Elad Sharon
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Matthew Dankner, Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A Nebhan, Ibiayi Dagogo-Jack, Nathaniel J Myall, Georg Richtig, Jillian Wilhelmina Paulina Bracht, Marco Gerlinger, Eiji Shinozaki, Takayuki Yoshino, Daisuke Kotani, Jason R Fangusaro, Oliver Gautschi, Julien Mazieres, Jeffrey A Sosman, Edmund S Kopetz, Vivek Subbiah, Michael A Davies, Anna L Groover, Ryan J Sullivan, Keith T Flaherty, Douglas B Johnson, Andrea Benedetti, David W Cescon, Anna Spreafico, George Zogopoulos, April A N Rose
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors. JCO precision oncology 6 (2022)
Abdul Rafeh Naqash, Douglas B Johnson, Javid J Moslehi, Elad Sharon
Reply to S. Rossi et al and P. Palassin et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Caroline A Nebhan, Douglas B Johnson
Pembrolizumab in the adjuvant treatment of melanoma: efficacy and safety. Expert review of anticancer therapy 21 (6) (2021)
Jordan J Wright, Alvin C Powers, Douglas B Johnson
Endocrine toxicities of immune checkpoint inhibitors. Nature reviews. Endocrinology 17 (7) (2021)
Sohini Roy, Tarsheen K Sethi, David Taylor, Young J Kim, Douglas B Johnson
Breakthrough concepts in immune-oncology: Cancer vaccines at the bedside. Journal of leukocyte biology 108 (4) (2020)
Brendan L Mangan, Renee K McAlister, Justin M Balko, Douglas B Johnson, Javid J Moslehi, Andrew Gibson, Elizabeth Jane Phillips
Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy. British journal of clinical pharmacology 86 (9) (2020)
James Randall Patrinley, Laura X Baker, Elizabeth J Davis, Haocan Song, Fei Ye, Douglas B Johnson
Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma. Cancer 126 (15) (2020)
Laura X Wang, Henry T Quach, Nikil V Moodabigil, Elizabeth J Davis, Jeffrey A Sosman, Stacie B Dusetzina, Douglas B Johnson
Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitors. Cancer 126 (2) (2019)
Douglas B Johnson, Wyatt J McDonnell, Paula I Gonzalez Ericsson, Rami N Al-Rohil, Bret C Mobley, Joe-Elie Salem, Daniel Y Wang, Violeta Sanchez, Yu Wang, Cody A Chastain, Kristi Barker, Yan Liang, Sarah Warren, Joseph M Beechem, Alexander M Menzies, Martin Tio, Georgina V Long, Justine V Cohen, Amanda C Guidon, Méabh O'Hare, Sunandana Chandra, Akansha Chowdhary, Bénédicte Lebrun-Vignes, Simone M Goldinger, Elisabeth J Rushing, Elizabeth I Buchbinder, Simon A Mallal, Chanjuan Shi, Yaomin Xu, Javid J Moslehi, Melinda E Sanders, Jeffrey A Sosman, Justin M Balko
A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis. Nature medicine 25 (8) (2019)
Ines Pires daSilva, Isabella C Glitza Oliva, Lauren E Haydu, Romany Johnpulle, Patricia D Banks, George D Grass, Simone M A Goldinger, Jessica L Smith, Ashlyn S Everett, Peter Koelblinger, Rachel Roberts-Thomson, Michael Millward, Victoria G Atkinson, Alexander Guminski, Rony Kapoor, Robert M Conry, Matteo S Carlino, Wei Wang, Mark J Shackleton, Zeynep Eroglu, Serigne N Lô, Angela M Hong, Georgina V Long, Douglas B Johnson, Alexander M Menzies
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies. Pigment cell & melanoma research 32 (4) (2019)
Douglas B Johnson, Ali Manouchehri, Alexandra M Haugh, Henry T Quach, Justin M Balko, Benedicte Lebrun-Vignes, Andrew Mammen, Javid J Moslehi, Joe-Elie Salem
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study. Journal for immunotherapy of cancer 7 (1) (2019)
Karim R Saab, Meghan J Mooradian, Daniel Y Wang, Jeewon Chon, Cathy Y Xia, Angelica Bialczak, Kelly T Abbate, Alexander M Menzies, Douglas B Johnson, Ryan J Sullivan, Alexander N Shoushtari
Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy. Cancer 125 (6) (2018)
Elizabeth J Davis, Douglas B Johnson, Jeffrey A Sosman, Sunandana Chandra
Melanoma: What do all the mutations mean? Cancer 124 (17) (2018)
Douglas B Johnson
Toxicities and outcomes: Do steroids matter? Cancer 124 (18) (2018)
Douglas B Johnson, Ryan J Sullivan, Alexander M Menzies
Immune checkpoint inhibitors in challenging populations. Cancer 123 (11) (2017)
Douglas B Johnson, Merrida A Childress, Zachary R Chalmers, Garrett M Frampton, Siraj M Ali, Samuel M Rubinstein, David Fabrizio, Jeffrey S Ross, Sohail Balasubramanian, Vincent A Miller, Philip J Stephens, Jeffrey A Sosman, Christine M Lovly
BRAF internal deletions and resistance to BRAF/MEK inhibitor therapy. Pigment cell & melanoma research 31 (3) (2017)
Tejaswi V Mudigonda, Kenneth Wyman, David R Spigel, Kimberly B Dahlman, F Anthony Greco, Igor Puzanov, Mark C Kelley, John D Hainsworth, Jeffrey A Sosman, Douglas B Johnson
A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma. Pigment cell & melanoma research 29 (1) (2015)